Acute Porphyria Drug Database

Monograph

D02AF - Salicylic Acid Preparations
Not porphyrinogenic
NP

Rationale
Vast experience and several references: safe
Chemical description
ASA-ointment for dermatological use. No data on absorbation. South African list: safe. Kalman, Bonkovsky: safe. Michael Moore’s list: safe. The Merck Manual: safe . Eales: Porphyria and the dangerous lifethreatening drugs, S Afr Med 56:914, 1979: safe. Thunell, clinical reports: safe (n=32)

Similar drugs
Explore alternative drugs in similar therapeutic classes D02A / D02AF or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Norway
Guttaplast · Salisylolje NAF · Salisylsyre SA · Salisylvaselin NAF
Poland
Acerin · Hasceral · Masc na odciski Gemi · Masc przeciw odciskom i zgrubieniom skóry Rekord Luszczy · Plaster na odciski · Salicylol · Sonol
Latvia
Salicilskabes · Salicilskabes-RFF · Salicylic acid · Salicylic acid Valentis
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙